The short version.
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are weekly injectable medications that suppress appetite via GLP-1 receptor pathways. Originally for type-2 diabetes, then approved for obesity in adults; Wegovy was approved for kids 12+ with obesity in 2022. The TikTok and Instagram conversation pushes the drugs to teens without medical obesity who want to thin out for prom, sports cut, or aesthetic.
The platforms and contexts.
TikTok (#GLP1, #SkinnyTok), Instagram, Reddit communities, telehealth platforms (Hims/Hers, Ro, Mochi Health, Sequence) that prescribe to anyone with a BMI-eligible claim — often without rigorous teen screening. Black-market compounded versions show up on Telegram and Discord.
The timeline.
GLP-1 cultural moment hit in 2022–2023 with adult celebrities. Teen misuse coverage in The Atlantic, NYT, and WSJ followed through 2024. AAP has issued cautious guidance; pediatric endocrinologists are documenting non-obese teens presenting with self-administered use.
The core facts a parent needs.
- GLP-1 drugs cause aggressive appetite suppression. In a teen with disordered-eating patterns, that's not a side effect — it's the desired effect, and it can fast-track an eating disorder.
- Muscle loss is a known issue (about 25–40% of weight lost is lean mass). For a teen still building bone density and muscle, that may carry lifelong consequences not yet quantified.
- Telehealth access is permissive. Some platforms ship without a real prescriber consult; some require a video with a clinician who has 7 minutes and a checkbox. Both can leave teens unscreened for ED.
What's actually at stake.
- Acceleration into anorexia or other restrictive ED, especially in teens with existing body-image vulnerability.
- Gallbladder disease, pancreatitis, severe vomiting requiring hospitalization — all documented at adult dosing, less studied in teens.
- Compounded / black-market versions: wrong dose, contamination, no clinical oversight. Already linked to ER visits.
The talk that lands — try it now.
Imagine you just learned your teen brushed up against this. You have 60 seconds before the conversation begins. What you say first decides whether the next 20 minutes opens the door — or slams it.
"What were you thinking? Give me your phone — now."
Panic + punishment in the same breath. The teen reads it as "every honest detail will be used against me." The phone comes; the truth doesn't.
What would you open with instead? Picture it for a beat — then…
"I want to ask about something — no trouble, I just want to understand it. Can we sit for five minutes?"
Curiosity, not court. Promise of safety in the first sentence. Time-bounded so it doesn't feel like a trap. Almost every teen says yes to five minutes.
Then, in those 5 minutes:
- If your teen brings up GLP-1s, don't dismiss — engage. Ask what they've read, what they're hoping it solves, and where they think they'd get it. Most parents only find out after the first injection.
- If your teen genuinely has obesity AND a clinical team you trust, the medication has real evidence. If your teen is normal-weight or you don't have a clinical team, the answer is no — and a referral to an adolescent-medicine specialist if body-image distress is the underlying driver.
- Audit the medicine cabinet and shipping. Self-prescribed telehealth ships boxes to your address. A weekly mystery box is a signal worth a conversation.
Try saying it out loud once before you close this tab. Cool parents rehearse — yelled parents wing it.
Practice 200 more parent–teen scripts →Concrete next steps.
- If your teen brings up GLP-1s, don't dismiss — engage. Ask what they've read, what they're hoping it solves, and where they think they'd get it. Most parents only find out after the first injection.
- If your teen genuinely has obesity AND a clinical team you trust, the medication has real evidence. If your teen is normal-weight or you don't have a clinical team, the answer is no — and a referral to an adolescent-medicine specialist if body-image distress is the underlying driver.
- Audit the medicine cabinet and shipping. Self-prescribed telehealth ships boxes to your address. A weekly mystery box is a signal worth a conversation.
National Eating Disorders Association Helpline 1-800-931-2237 · 988 Crisis Lifeline · Adolescent-medicine specialist · Pediatric endocrinologist for legitimate obesity care.
